222

U2BIO CO., LTD.

No trades
See on Supercharts

221800 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

U2Bio Co., Ltd. engages in the provision of in vitro diagnostics and medical information technology (IT) services. It operates through the following business areas: In vitro diagnostics services, Medical IT Solutions, and New Business. In vitro diagnostics business offers general diagnostic tests, molecular diagnostic tests, and research authorization clinical services. The Medical IT solution business provides medical practitioner-centered health examination, specialized medical examination and diagnostic equipment, and electronic medical record interworking solutions. The New Business area focuses on clinical trial services and personalized healthcare solutions. The company was founded on January 2, 2009 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

221800 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company